FRAMINGHAM (09/24/2003) - Robotic liquid handling systems are expected to play a larger role in the life sciences as they will be increasingly used in a variety of drug discovery applications. Those are the findings of a recent Frost & Sullivan Inc. study titled "World Robotics in Biology: Liquid Handling Market." The study found that in 2002, the primary use for such robotic systems was in diagnostic applications. But the study noted that the life science industry is seeking tools that automate and speed up the drug discovery process. To that end, the study suggests robotic liquid handling systems will play a larger role in genomic- and proteomic-based high-throughput lab work. As a result, Frost & Sullivan predicts the total market revenue for robotic liquid handling systems will rise from US$555 million in 2002 to over $1.2 billion in 2009.